Right now, the drugs come with a hefty price tag. Ozempic typically runs 8,800 to 11,000 rupees ($95–$119) per month, while ...

In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster ...

Novo Nordisk is facing generics of its GLP-1 drug in India, Atrogi is testing a new weight loss approach, and there's new data on Structure's lead drug. Indian patent on semagluti ...

The simultaneous patent expiry of Ozempic’s active ingredient in China and India on Friday is a watershed moment. Until now, the revolutionary weight-loss drugs have been available largely to people ...

WINNIPEG, MB - March 05, 2026 - PRESSADVANTAGE - BuyCanadianInsulin.com reports that generic semaglutide may become ...

Don't let sleek packaging fool you. These common budget products offer the exact same performance as the premium brands.

Move comes 2 years after controversial exit of brand-name product ...

Half of US generic drugs are made in India and transit the Strait of Hormuz. Supply chains prepare for emergencies, but prescription stockpiles are limited.

This article was produced in partnership with The New York Times. Not all drug prices are going up. Amid the public fury over the escalating costs of brand-name medications, the prices of generic ...

Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...